메뉴 건너뛰기




Volumn 21, Issue SUPPL. 2, 2010, Pages 403-406

Microarchitecture in focus

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; BONE DENSITY CONSERVATION AGENT;

EID: 79953009097     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1242-1     Document Type: Review
Times cited : (7)

References (30)
  • 1
    • 0007630875 scopus 로고    scopus 로고
    • Preclinical evaluation of new therapeutic agents for osteoporosis
    • Meunier PJ (ed) Dunitz, London
    • Ammann P, Rizzoli R, Bonjour JP (1998) Preclinical evaluation of new therapeutic agents for osteoporosis. In: Meunier PJ (ed) Osteoporosis: diagnosis and management. Dunitz, London, pp 257-273
    • (1998) Osteoporosis: Diagnosis and Management , pp. 257-273
    • Ammann, P.1    Rizzoli, R.2    Bonjour, J.P.3
  • 3
    • 1642292806 scopus 로고    scopus 로고
    • Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy
    • Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599-604
    • (2004) Bone , vol.34 , pp. 599-604
    • Delmas, P.D.1    Seeman, E.2
  • 5
    • 40149099326 scopus 로고    scopus 로고
    • Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair
    • Kalpakcioglu BB, Morshed S, Engelke K, Genant HK (2008) Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair. J Bone Joint Surg Am 90(Suppl 1):68-78
    • (2008) J Bone Joint Surg Am , vol.90 , Issue.SUPPL. 1 , pp. 68-78
    • Kalpakcioglu, B.B.1    Morshed, S.2    Engelke, K.3    Genant, H.K.4
  • 7
    • 84862549926 scopus 로고    scopus 로고
    • Measuring bone quality and bone strength
    • Elsevier-Masson
    • Bouxsein ML (2009) Measuring bone quality and bone strength. In: Innovation in skeletal medicine. Elsevier-Masson, pp 85-98
    • (2009) Innovation in Skeletal Medicine , pp. 85-98
    • Bouxsein, M.L.1
  • 8
    • 44849107299 scopus 로고    scopus 로고
    • Technology insight: Noninvasive assessment of bone strength in osteoporosis
    • Bouxsein ML (2008) Technology insight: noninvasive assessment of bone strength in osteoporosis. Nat Clin Pract Rheumatol 4 (6):310-318
    • (2008) Nat Clin Pract Rheumatol , vol.4 , Issue.6 , pp. 310-318
    • Bouxsein, M.L.1
  • 9
    • 2442654174 scopus 로고    scopus 로고
    • Bone mineral density thresholds for pharmacological intervention to prevent fractures
    • Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108-1112
    • (2004) Arch Intern Med , vol.164 , pp. 1108-1112
    • Siris, E.S.1    Chen, Y.T.2    Abbott, T.A.3
  • 10
    • 0942268144 scopus 로고    scopus 로고
    • Fracture incidence and association with bone mineral density in elderly men and women: The rotterdam study
    • Schuit SC, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34:195-202
    • (2004) Bone , vol.34 , pp. 195-202
    • Schuit, S.C.1    Van Der Klift, M.2    Weel, A.E.3
  • 11
    • 38549175745 scopus 로고    scopus 로고
    • Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
    • Arlot ME, Jiang Y, Genant HK et al (2008) Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res 23:215-222
    • (2008) J Bone Miner Res , vol.23 , pp. 215-222
    • Arlot, M.E.1    Jiang, Y.2    Genant, H.K.3
  • 12
    • 0029975485 scopus 로고    scopus 로고
    • Assessment of cancellous bone structure: Comparison of strut analysis, trabecular bone pattern factor and marrow space star volume
    • Croucher PI, Garrahan NJ, Compston JE (1996) Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor and marrow space star volume. J Bone Miner Res 11:955-961
    • (1996) J Bone Miner Res , vol.11 , pp. 955-961
    • Croucher, P.I.1    Garrahan, N.J.2    Compston, J.E.3
  • 13
    • 84864304634 scopus 로고    scopus 로고
    • Microarchitecture, the key to bone quality
    • Brandi ML (2009) Microarchitecture, the key to bone quality. Rheumatology 48:iv3-iv8
    • (2009) Rheumatology , vol.48
    • Brandi, M.L.1
  • 15
    • 27944449749 scopus 로고    scopus 로고
    • In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography
    • Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508-6515
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6508-6515
    • Boutroy, S.1    Bouxsein, M.L.2    Munoz, F.3    Delmas, P.D.4
  • 16
    • 29644439392 scopus 로고    scopus 로고
    • Effects of sex and age on bone microstructure at the ultradistal radius: A population-based noninvasive in vivo assessment
    • Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M et al (2006) Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res 21:124-131
    • (2006) J Bone Miner Res , vol.21 , pp. 124-131
    • Khosla, S.1    Riggs, B.L.2    Atkinson, E.J.3    Oberg, A.L.4    McDaniel, L.J.5    Holets, M.6
  • 17
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators
    • Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637-645
    • (1999) JAMA , vol.282 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 18
    • 0036133366 scopus 로고    scopus 로고
    • Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
    • Riggs BL, Melton LJ 3rd (2002) Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 17:11-14
    • (2002) J Bone Miner Res , vol.17 , pp. 11-14
    • Riggs, B.L.1    Melton III, L.J.2
  • 19
    • 0036284616 scopus 로고    scopus 로고
    • Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents
    • Hochberg MC, Greenspan S, Wasnich RD et al (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586-1592
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 1586-1592
    • Hochberg, M.C.1    Greenspan, S.2    Wasnich, R.D.3
  • 20
    • 0028851590 scopus 로고
    • Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
    • the Alendronate Phase III Osteoporosis Treatment Study Group
    • Liberman UA, Weiss SR, Bröll J, the Alendronate Phase III Osteoporosis Treatment Study Group et al (1995) N Engl J Med 333:1437-1443, Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
    • (1995) N Engl J Med , vol.333 , pp. 1437-1443
    • Liberman, U.A.1    Weiss, S.R.2    Bröll, J.3
  • 21
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group
    • Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535-1541
    • (1996) Lancet , vol.348 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 22
    • 0030664688 scopus 로고    scopus 로고
    • Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
    • Delmas PD, Bjarnason NH, Mitlak BH et al (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337:1641-1647
    • (1997) N Engl J Med , vol.337 , pp. 1641-1647
    • Delmas, P.D.1    Bjarnason, N.H.2    Mitlak, B.H.3
  • 23
    • 0036119735 scopus 로고    scopus 로고
    • Improvement in spine bone density and reduction in risk of vertebral fractures during treatment antiresorptive drugs
    • Cummings SR, Karpf DB, Harris F et al (2002) Improvement in Spine Bone Density and reduction in risk of vertebral fractures during treatment antiresorptive drugs. Am J Med 112 (4):281-289
    • (2002) Am J Med , vol.112 , Issue.4 , pp. 281-289
    • Cummings, S.R.1    Karpf, D.B.2    Harris, F.3
  • 24
    • 0029898269 scopus 로고    scopus 로고
    • Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats
    • Ammann P, Rizzoli R, Meyer JM et al (1996) Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats. Osteoporos Int 6:219-227
    • (1996) Osteoporos Int , vol.6 , pp. 219-227
    • Ammann, P.1    Rizzoli, R.2    Meyer, J.M.3
  • 25
    • 0027139913 scopus 로고
    • The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primate
    • Balena R, Toolan BC, Shea M et al (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primate. J Clin Invest 92:2577-86
    • (1993) J Clin Invest , vol.92 , pp. 2577-2586
    • Balena, R.1    Toolan, B.C.2    Shea, M.3
  • 27
    • 34547567305 scopus 로고    scopus 로고
    • The correction of BMD measurements for bone strontium content
    • Blake GM, Fogelman I (2007) The correction of BMD measurements for bone strontium content. J Clin Densitom 10:259-265
    • (2007) J Clin Densitom , vol.10 , pp. 259-265
    • Blake, G.M.1    Fogelman, I.2
  • 28
    • 34547790885 scopus 로고    scopus 로고
    • Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate
    • Bruyere O, Roux C, Detilleux J et al (2007) Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 92:3076-3081
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 3076-3081
    • Bruyere, O.1    Roux, C.2    Detilleux, J.3
  • 29
    • 37749000351 scopus 로고    scopus 로고
    • Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate
    • Bruyère O, Roux C, Badurski J et al (2007) Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin 23:3041-3045
    • (2007) Curr Med Res Opin , vol.23 , pp. 3041-3045
    • Bruyère, O.1    Roux, C.2    Badurski, J.3
  • 30
    • 77953312035 scopus 로고    scopus 로고
    • Superiority of strontium ranelate as compared to alendronate on microstructural determinants of bone strength at the distal tibia in women with postmenopausal osteoporosis
    • Rizzoli R, Felsenberg D, Laroche M et al (2009) Superiority of strontium ranelate as compared to alendronate on microstructural determinants of bone strength at the distal tibia in women with postmenopausal osteoporosis. Ann Rheum Dis 68:669
    • (2009) Ann Rheum Dis , vol.68 , pp. 669
    • Rizzoli, R.1    Felsenberg, D.2    Laroche, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.